SonoThera announced that it received exclusive global commercial licensing rights from GE HealthCare (NYSE:GEHC) for two of its microbubble products. South San Francisco-based SonoThera received the rights for the Optison and Sonazoid microbubble products. It uses them in the development of its novel, ultrasound-guided nonviral gene therapy platform. According to SonoThera co-founder and CEO Kenneth […]
